Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Christine Duncan, Justine Kahn, Stephan A. Grupp & Paul G. Richardson. (2019) Recent developments with defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome. Expert Opinion on Orphan Drugs 7:7-8, pages 337-347.
Read now
Read now
Paul G. Richardson, Brandon M. Triplett, Vincent T. Ho, Nelson Chao, Fiona L. Dignan, Michelle Maglio & Mohamad Mohty. (2018) Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome. Expert Review of Clinical Pharmacology 11:2, pages 113-124.
Read now
Read now
Selim Corbacioglu & Paul G. Richardson. (2017) Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation. Expert Review of Gastroenterology & Hepatology 11:10, pages 885-898.
Read now
Read now
Alessandro Fulgenzi & Maria Elena Ferrero. (2016) Defibrotide in the treatment of hepatic veno-occlusive disease. Hepatic Medicine: Evidence and Research 8, pages 105-113.
Read now
Read now
Paola Tocchetti, Elena Tudone, Jean-Francois Marier, Thomas C Marbury, Katie Zomorodi & Mark Eller. (2016) Pharmacokinetic profile of defibrotide in patients with renal impairment. Drug Design, Development and Therapy 10, pages 2631-2641.
Read now
Read now
Paul G Richardson, Amrita Krishnan, Sergio Giralt & Robert J Soiffer. (2015) Defibrotide for the treatment of severe hepatic veno-occlusive disease/sinusoidal obstruction syndrome: evidence for clinical benefit. Expert Opinion on Orphan Drugs 3:12, pages 1491-1501.
Read now
Read now
Gösta Gahrton & Amrita Krishnan. (2014) Allogeneic transplantation in multiple myeloma. Expert Review of Hematology 7:1, pages 79-90.
Read now
Read now
Articles from other publishers (55)
Dristhi S. Ragoonanan, Brandon Douglas Brown & Kris M. Mahadeo. 2024. Manual of Hematopoietic Cell Transplantation and Cellular Therapies. Manual of Hematopoietic Cell Transplantation and Cellular Therapies
481
507
.
Orly R. Klein, Yiouli P. Ktena, Elizabeth Pierce, Han-Hsuan Fu, Azeb Haile, Chen Liu & Kenneth R. Cooke. (2023) Defibrotide modulates pulmonary endothelial cell activation and protects against lung inflammation in pre-clinical models of LPS-induced lung injury and idiopathic pneumonia syndrome. Frontiers in Immunology 14.
Crossref
Crossref
Yan Han, Alan Bidgoli, Brittany P. DePriest, Alejandra Méndez, Khadijeh Bijangi-Vishehsaraei, Evelio D. Perez-Albuerne, Robert A. Krance, Jamie Renbarger, Jodi L. Skiles, Sung W. Choi, Hao Liu & Sophie Paczesny. (2023) Prospective assessment of risk biomarkers of sinusoidal obstruction syndrome after hematopoietic cell transplantation. JCI Insight 8:10.
Crossref
Crossref
Stephan A Grupp, Selim Corbacioglu, Hyoung Jin Kang, Takanori Teshima, Seong Lin Khaw, Franco Locatelli, Johan Maertens, Matthias Stelljes, Polina Stepensky, Paty Lopez, Vian Amber, Antonio Pagliuca, Paul G Richardson & Mohamad Mohty. (2023) Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial. The Lancet Haematology 10:5, pages e333-e345.
Crossref
Crossref
Mohamad Mohty, Didier Blaise, Régis Peffault de Latour, Myriam Labopin, Jean Henri Bourhis, Benedicte Bruno, Patrice Ceballos, Marie Detrait, Virginie Gandemer, Anne Huynh, Faezeh Izadifar-Legrand, Charlotte Jubert, Hélène Labussière-Wallet, Delphine Lebon, Sébastien Maury, Catherine Paillard, Cécile Pochon, Cecile Renard, Fanny Rialland, Pascale Schneider, Anne Sirvent, Kobby Asubonteng, Gwennaëlle Guindeuil, Ibrahim Yakoub-Agha & Jean-Hugues Dalle. (2022) Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study. Bone Marrow Transplantation 58:4, pages 367-376.
Crossref
Crossref
Santosh Putta, Bradford A. Young, John E. Levine, Ran Reshef, Ryotaro Nakamura, Christopher Strouse, Miguel-Angel Perales, Alan Howard, Polly Pine, Ju Shi, Peixin Zhang, Vincent T. Ho & Wael Saber. (2023) Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study. Transplantation and Cellular Therapy 29:3, pages 166.e1-166.e10.
Crossref
Crossref
Shoichiro Mizukami, Tatsuya Shonaka, Chikayoshi Tani, Kazuki Ihara, Tomohiro Takeda, Mizuho Ohara, Kimiharu Hasegawa, Mishie Tanino, Koji Sawada & Yasuo Sumi. (2022) A case of percutaneous transhepatic stomal varices embolization and partial splenic artery embolization for rectal cancer after CAPOX/BEV chemotherapy: the summary of the stomal varices related to oxaliplatin administration. Clinical Journal of Gastroenterology 16:1, pages 54-62.
Crossref
Crossref
Dionysios Vythoulkas, Panagiotis Tsirigotis, Marianna Griniezaki, Ioannis Konstantellos & Ioanna Lazana. (2023) Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation. Cancers 15:3, pages 680.
Crossref
Crossref
Elisabeth Wallhult, Michelle Kenyon & Barry Quinn. 2023. The European Blood and Marrow Transplantation Textbook for Nurses. The European Blood and Marrow Transplantation Textbook for Nurses
185
216
.
Michelle Hudspeth, Shahram Mori, David Nachbaur, José Antonio Perez-Simon, Friedrich Stölzel, Marcie Riches, Wendy Wu, Peixin Zhang, Shirali Agarwal & Ibrahim Yakoub-Agha. (2022) A phase II, prospective, randomized, open-label study of defibrotide added to standard-of-care prophylaxis for the prevention of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation. Haematologica 108:4, pages 1026-1038.
Crossref
Crossref
Selim Corbacioglu, Ozlem Topaloglu & Saurabh Aggarwal. (2022) A Systematic Review and Meta-Analysis of Studies of Defibrotide Prophylaxis for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome. Clinical Drug Investigation 42:6, pages 465-476.
Crossref
Crossref
Mohamad Mohty, Marta Lisa Battista, Didier Blaise, Elisabetta Calore, Simone Cesaro, Natalia Maximova, Katia Perruccio, Cecile Renard, Robert Wynn, Marco Zecca, Myriam Labopin, Raj Hanvesakul, Vian Amber, Robert J. Ryan, Sarah Lawson & Fabio Ciceri. (2021) A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study. Bone Marrow Transplantation 56:10, pages 2454-2463.
Crossref
Crossref
Hui Shi, Alex A. Gandhi, Stephanie A. Smith, Qiuyu Wang, Diane Chiang, Srilakshmi Yalavarthi, Ramadan A. Ali, Chao Liu, Gautam Sule, Pei-Suen Tsou, Yu Zuo, Yogendra Kanthi, Evan A. Farkash, Jiandie D. Lin, James H. Morrissey & Jason S. Knight. (2021) Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide. JCI Insight 6:17.
Crossref
Crossref
Hannes Treiber, Alexander König, Albrecht Neesse, Annika Richter, Carsten Oliver Sahlmann & Arne Strauss. (2021)
Liver Enzyme Elevation After
177
Lu-PSMA Radioligand Therapy for Metastasized Castration-Resistant Prostate Cancer
. Journal of Nuclear Medicine 62:7, pages 1016-1019.
Crossref
Crossref
Eleonora Calabretta, Jose M. Moraleda, Massimo Iacobelli, Ruben Jara, Israel Vlodavsky, Peter O’Gorman, Antonio Pagliuca, Clifton Mo, Rebecca M. Baron, Alessio Aghemo, Robert Soiffer, Jawed Fareed, Carmelo Carlo‐Stella & Paul Richardson. (2021) COVID‐19‐induced endotheliitis: emerging evidence and possible therapeutic strategies. British Journal of Haematology 193:1, pages 43-51.
Crossref
Crossref
Yasuyuki Inoue, Shigeki Kosugi & Fumiaki Sano. (2021) Improvement of High Serum Levels of Biomarkers of Endothelial Injury (Vascular Cell Adhesion Molecule-1) and Inflammation (Tumor Necrosis Factor Receptor Type I) After Allogeneic Hematopoietic Stem Cell Transplantation With Sinusoidal Obstruction Syndrome Using Defibrotide. American Journal of Therapeutics 28:6, pages e691-e693.
Crossref
Crossref
Paul G. Richardson, Angela R. Smith, Nancy A. Kernan, Leslie Lehmann, Robert J. Ryan & Stephan A. Grupp. (2021) Analysis of Time to Complete Response after Defibrotide Initiation in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy 27:1, pages 88.e1-88.e6.
Crossref
Crossref
Peter Lang, Thomas Eichholz, Tamam Bakchoul, Monika Streiter, Maurice Petrasch, Hans Bösmüller, Reinhild Klein, Armin Rabsteyn, Anne-Marie Lang, Constantin Adams, Karin Klingel, Michaela Gessner, Peter Rosenberger, Peter Ruef & Rupert Handgretinger. (2020) Defibrotide for the Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2 Pediatric Patients. Journal of the Pediatric Infectious Diseases Society 9:5, pages 622-625.
Crossref
Crossref
E. B. Machneva, M. A. Bolokhonova, T. Z. Aliev, D. V. Shevtsov, A. M. Suleymanova, N. V. Sidorova, E. A. Osmanov & K. I. Kirgizov. (2020) Thrombotic microangiopathy associated with hematopoietic stem cell transplantation: general characteristics and an example from clinical practice. Russian Journal of Pediatric Hematology and Oncology 7:3, pages 86-93.
Crossref
Crossref
Mitchell S. Cairo, Kenneth R. Cooke, Hillard M. Lazarus & Nelson Chao. (2020) Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation. British Journal of Haematology 190:6, pages 822-836.
Crossref
Crossref
Gerhard C. Hildebrandt & Nelson Chao. (2020) Endothelial cell function and endothelial‐related disorders following haematopoietic cell transplantation. British Journal of Haematology 190:4, pages 508-519.
Crossref
Crossref
Selim Corbacioglu, Nancy A. Kernan, Antonio Pagliuca, Robert J. Ryan, William Tappe & Paul G. Richardson. (2020) Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients. Biology of Blood and Marrow Transplantation 26:7, pages 1342-1349.
Crossref
Crossref
Yu Zuo, Hui Shi, Chun LiJason S. Knight. (2020) Antiphospholipid syndrome: a clinical perspective. Chinese Medical Journal 133:8, pages 929-940.
Crossref
Crossref
Mohamad Mohty, Florent Malard, Manuel Abecasis, Erik Aerts, Ahmed S. Alaskar, Mahmoud Aljurf, Mutlu Arat, Peter Bader, Frederic Baron, Grzegorz Basak, Ali Bazarbachi, Didier Blaise, Fabio Ciceri, Selim Corbacioglu, Jean-Hugues Dalle, Fiona Dignan, Takahiro Fukuda, Anne Huynh, Jurgen Kuball, Silvy Lachance, Hillard Lazarus, Tamas Masszi, Mauricette Michallet, Arnon Nagler, Mairead NiChonghaile, Shinichiro Okamoto, Antonio Pagliuca, Christina Peters, Finn B. Petersen, Paul G. Richardson, Tapani Ruutu, Wael Saber, Bipin N. Savani, Robert Soiffer, Jan Styczynski, Elisabeth Wallhult, Ibrahim Yakoub-Agha, Rafael F. Duarte & Enric Carreras. (2019) Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group. Bone Marrow Transplantation 55:3, pages 485-495.
Crossref
Crossref
William Tappe, Saurabh Aggarwal, Ozlem Topaloglu & Massimo Iacobelli. (2020) A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting. Clinical and Applied Thrombosis/Hemostasis 26, pages 107602962093520.
Crossref
Crossref
Alireza Shahryari, Marie Saghaeian Jazi, Saeed Mohammadi, Hadi Razavi Nikoo, Zahra Nazari, Elaheh Sadat Hosseini, Ingo Burtscher, Seyed Javad Mowla & Heiko Lickert. (2019) Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders. Frontiers in Genetics 10.
Crossref
Crossref
Sunita Nathan & Celalettin Ustun. (2019) Complications of Stem Cell Transplantation that Affect Infections in Stem Cell Transplant Recipients, with Analogies to Patients with Hematologic Malignancies. Infectious Disease Clinics of North America 33:2, pages 331-359.
Crossref
Crossref
Nancy A. Kernan, Paul G. Richardson, Angela R. Smith, Brandon M. Triplett, Joseph H. Antin, Leslie Lehmann, Yoav Messinger, Wei Liang, Robin Hume, William Tappe, Robert J. Soiffer & Stephan A. Grupp. (2018) Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access program. Pediatric Blood & Cancer 65:10, pages e27269.
Crossref
Crossref
Paul G. RichardsonEnric CarrerasMassimo Iacobelli & Bijan Nejadnik. (2018) The use of defibrotide in blood and marrow transplantation. Blood Advances 2:12, pages 1495-1509.
Crossref
Crossref
Nancy A. Kernan, Stephan Grupp, Angela R. Smith, Sally Arai, Brandon Triplett, Joseph H. Antin, Leslie Lehmann, Tsiporah Shore, Vincent T. Ho, Nancy Bunin, Massimo Iacobelli, Wei Liang, Robin Hume, William Tappe, Robert Soiffer & Paul Richardson. (2018) Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome. British Journal of Haematology 181:6, pages 816-827.
Crossref
Crossref
Rupesh Raina, Ghada A. Abusin, Prashant Vijayaraghavan, Jeffery J. Auletta, Linda Cabral, Hasan Hashem, Beth A. Vogt, Kenneth R. Cooke & Rolla F. Abu‐Arja. (2018) The role of continuous renal replacement therapy in the management of acute kidney injury associated with sinusoidal obstruction syndrome following hematopoietic cell transplantation. Pediatric Transplantation 22:2.
Crossref
Crossref
John Coutsouvelis, Sharon Avery, Michael Dooley, Carl Kirkpatrick & Andrew Spencer. (2017) Defibrotide for the treatment of sinusoidal obstruction syndrome: evaluation of response to therapy and patient outcomes. Supportive Care in Cancer 26:3, pages 947-955.
Crossref
Crossref
Mairéad Ní Chonghaile & Karen Wolownik. (2018) Identification and Management: Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Eelated to Hematopoietic Stem Cell Transplantation
. Clinical Journal of Oncology Nursing 22:1, pages E7-E17.
Crossref
Crossref
Valerie I. Brown. 2018. Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist. Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist
215
233
.
Elisabeth Wallhult & Barry Quinn. 2018. The European Blood and Marrow Transplantation Textbook for Nurses. The European Blood and Marrow Transplantation Textbook for Nurses
163
195
.
Raif Nasre Nasser, Magdalena Correa VegaNorlis Colmenares ÁlvarezMariener Sánchez DugarteMartí Quevedo Pinos. (2017) Enfermedad Veno-oclusiva Hepática/Síndrome de Obstrucción Sinusoidal: actualización de los aspectos fisiopatológicos, criterios diagnósticos y opciones terapéuticas.. Oncología (Ecuador), pages 168-188.
Crossref
Crossref
Paul G Richardson, Stephan A Grupp, Antonio Pagliuca, Amrita Krishnan, Vincent T Ho & Selim Corbacioglu. (2017) Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan failure. International Journal of Hematologic Oncology 6:3, pages 75-93.
Crossref
Crossref
Paul G. Richardson, Angela R. Smith, Brandon M. Triplett, Nancy A. Kernan, Stephan A. Grupp, Joseph H. Antin, Leslie Lehmann, Maja Miloslavsky, Robin Hume, Alison L. Hannah, Bijan Nejadnik & Robert J. Soiffer. (2017) Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation. British Journal of Haematology 178:1, pages 112-118.
Crossref
Crossref
Paul G. Richardson, Angela R. Smith, Brandon M. Triplett, Nancy A. Kernan, Stephan A. Grupp, Joseph H. Antin, Leslie Lehmann, Tsiporah Shore, Massimo Iacobelli, Maja Miloslavsky, Robin Hume, Alison L. Hannah, Bijan Nejadnik & Robert J. Soiffer. (2017) Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study. Biology of Blood and Marrow Transplantation 23:6, pages 997-1004.
Crossref
Crossref
Francesco Squadrito, Alessandra Bitto, Natasha Irrera, Gabriele Pizzino, Giovanni Pallio, Letteria Minutoli & Domenica Altavilla. (2017) Pharmacological Activity and Clinical Use of PDRN. Frontiers in Pharmacology 8.
Crossref
Crossref
Elisabeth Wallhult, Michelle Kenyon, Sarah Liptrott, Arno Mank, Mairéad Ní Chonghaile, Aleksandra Babic, Jacobine Bijkerk, Caroline Bompoint, Selim Corbacioglu, Roel de Weijer, Claudia Fink, Sarah Marktel, Vivek Soni, Sarah Sprenger, Eugenia Trigoso Arjona & Mohamad Mohty. (2017) Management of veno‐occlusive disease: the multidisciplinary approach to care. European Journal of Haematology 98:4, pages 322-329.
Crossref
Crossref
A Colecchia, G Marasco, F Ravaioli, K Kleinschmidt, R Masetti, A Prete, A Pession & D Festi. (2016) Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT. Bone Marrow Transplantation 52:3, pages 494-497.
Crossref
Crossref
Julie Steelandt, François Bocquet, Anne-Laure Cordonnier, Charlotte De Courtivron, Isabelle Fusier & Pascal Paubel. (2017) Defibrotide in Severe Sinusoidal Obstruction Syndrome: Medicine and Economic Issues. Biology of Blood and Marrow Transplantation 23:2, pages 347-356.
Crossref
Crossref
Selim Corbacioglu, Enric Carreras, Mohamad Mohty, Antonio Pagliuca, Jaap Jan Boelens, Gandhi Damaj, Massimo Iacobelli, Dietger Niederwieser, Eduardo Olavarría, Felipe Suarez, Tapani Ruutu, Leo Verdonck, Robin Hume, Bijan Nejadnik, Chinglin Lai, Giorgia Finetto & Paul Richardson. (2016) Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: Final Results From the International Compassionate-Use Program. Biology of Blood and Marrow Transplantation 22:10, pages 1874-1882.
Crossref
Crossref
Dominique-Charles Valla & Dominique Cazals-Hatem. (2016) Sinusoidal obstruction syndrome. Clinics and Research in Hepatology and Gastroenterology 40:4, pages 378-385.
Crossref
Crossref
Oliver Tavabie & Abid R. Suddle. (2016) Lymphoma and hematological conditions: I. Lymphoma and liver complications of bone marrow transplant. Clinical Liver Disease 8:1, pages 1-5.
Crossref
Crossref
Marta Palomo, Enrique Mir, Montse Rovira, Ginés Escolar, Enric Carreras & Maribel Diaz-Ricart. (2016) What is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romance. Blood 127:13, pages 1719-1727.
Crossref
Crossref
Brandon M. Triplett, Hani I. Kuttab, Guolian Kang & Wing Leung. (2015) Escalation to High-Dose Defibrotide in Patients with Hepatic Veno-Occlusive Disease. Biology of Blood and Marrow Transplantation 21:12, pages 2148-2153.
Crossref
Crossref
David M. Hockenbery, Simone I. Strasser & George B. McDonald. 2015. Thomas’ Hematopoietic Cell Transplantation. Thomas’ Hematopoietic Cell Transplantation
1140
1160
.
M Mohty, F Malard, M Abecassis, E Aerts, A S Alaskar, M Aljurf, M Arat, P Bader, F Baron, A Bazarbachi, D Blaise, F Ciceri, S Corbacioglu, J-H Dalle, R F Duarte, T Fukuda, A Huynh, T Masszi, M Michallet, A Nagler, M NiChonghaile, T Pagluica, C Peters, F B Petersen, P G Richardson, T Ruutu, B N Savani, E Wallhult, I Yakoub-Agha & E Carreras. (2015) Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation 50:6, pages 781-789.
Crossref
Crossref
Gösta Gahrton. (2015) Allogeneic transplantation in multiple myeloma – How, when or at all?. Acta Haematologica Polonica 46:3, pages 224-232.
Crossref
Crossref
Gillian M. Keating. (2014) Defibrotide: A Review of Its Use in Severe Hepatic Veno-Occlusive Disease Following Haematopoietic Stem Cell Transplantation. Clinical Drug Investigation 34:12, pages 895-904.
Crossref
Crossref
Gregory A. Yanik, Kenneth R. Cooke, Vincent T. Ho & Paul G. Richardson. 2014. Hematopoietic Cell Transplantation in Children with Cancer. Hematopoietic Cell Transplantation in Children with Cancer
77
102
.
Xuchen Zhang, Jie Ouyang & Swan N. Thung. (2013) Histopathologic Manifestations of Drug-induced Hepatotoxicity. Clinics in Liver Disease 17:4, pages 547-564.
Crossref
Crossref
R. Pescador, L. Capuzzi, M. Mantovani, A. Fulgenzi & M.E. Ferrero. (2013) Defibrotide: Properties and clinical use of an old/new drug. Vascular Pharmacology 59:1-2, pages 1-10.
Crossref
Crossref